These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7214296

  • 1. Active specific immunotherapy of stage IV renal carcinoma with aggregated tumor antigen adjuvant.
    Neidhart JA, Murphy SG, Hennick LA, Wise HA.
    Cancer; 1980 Sep 01; 46(5):1128-34. PubMed ID: 7214296
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study.
    Galligioni E, Quaia M, Merlo A, Carbone A, Spada A, Favaro D, Santarosa M, Sacco C, Talamini R.
    Cancer; 1996 Jun 15; 77(12):2560-6. PubMed ID: 8640706
    [Abstract] [Full Text] [Related]

  • 3. Failure of immunotherapy for metastatic renal cell carcinoma.
    Fowler JE.
    J Urol; 1986 Jan 15; 135(1):22-5. PubMed ID: 3510318
    [Abstract] [Full Text] [Related]

  • 4. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
    Chang AE, Aruga A, Cameron MJ, Sondak VK, Normolle DP, Fox BA, Shu S.
    J Clin Oncol; 1997 Feb 15; 15(2):796-807. PubMed ID: 9053507
    [Abstract] [Full Text] [Related]

  • 5. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM, Cerni C, Micksche M.
    Oncology; 1977 Feb 15; 34(5):229-33. PubMed ID: 917456
    [Abstract] [Full Text] [Related]

  • 6. Bacillus Calmette-Guerin in the treatment of adenocarcinoma of the kidney.
    Morales A, Eidinger D.
    J Urol; 1976 Apr 15; 115(4):377-80. PubMed ID: 1263310
    [Abstract] [Full Text] [Related]

  • 7. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
    Chang AE, Yoshizawa H, Sakai K, Cameron MJ, Sondak VK, Shu S.
    Cancer Res; 1993 Mar 01; 53(5):1043-50. PubMed ID: 8439951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED.
    J Urol; 2000 Apr 01; 163(4):1124-9. PubMed ID: 10737480
    [Abstract] [Full Text] [Related]

  • 10. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA.
    Eur Urol; 2016 Jun 01; 69(6):1046-52. PubMed ID: 26803476
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
    Margel D, Tal R, Golan S, Kedar D, Engelstein D, Baniel J.
    Urology; 2007 Jan 01; 69(1):78-82. PubMed ID: 17270621
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects.
    Adler A, Gillon G, Lurie H, Shaham J, Loven D, Shachter Y, Shani A, Servadio C, Stein JA.
    J Biol Response Mod; 1987 Dec 01; 6(6):610-24. PubMed ID: 3330126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.